Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Renal denervation in patients with heart failure secondary to Chagas' disease: A pilot randomized controlled trial.

Spadaro AG, Bocchi EA, Souza GE, Filho AE, Mariani J Jr, Campos CM, Lemos PA.

Catheter Cardiovasc Interv. 2019 Jul 23. doi: 10.1002/ccd.28393. [Epub ahead of print]

PMID:
31334914
2.

Molecular modeling and biological studies show that some μ-opioid receptor agonists might elicit analgesia acting as MMP-9 inhibitors.

Ronsisvalle S, Spadaro A, Tomasello B, Basile L, Panarello F, Franchini S, Renis M, Guccione S, Crascì L, Panico AM.

Future Med Chem. 2019 Jun;11(11):1245-1258. doi: 10.4155/fmc-2018-0535. Epub 2019 Apr 12.

PMID:
30974972
3.

Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells.

Zappalà A, Vicario N, Calabrese G, Turnaturi R, Pasquinucci L, Montenegro L, Spadaro A, Parenti R, Parenti C.

Nat Prod Res. 2019 Apr 2:1-7. doi: 10.1080/14786419.2019.1587428. [Epub ahead of print]

PMID:
30938188
4.

Mechanical, chemical and antimicrobial properties of a bisphenol A-free pit-and-fissure sealant.

Fiorati-Aguiar SM, Lucisano MP, Silva LABD, Silva RABD, Spadaro ACC, Borsatto MC, Nelson-Filho P.

Am J Dent. 2018 Dec;31(6):279-284.

PMID:
30658372
5.

Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.

Pirosa MC, Leotta S, Cupri A, Stella S, Martino EA, Scalise L, Sapienza G, Calafiore V, Mauro E, Spadaro A, Vigneri P, Di Raimondo F, Milone G.

Chemotherapy. 2018;63(4):220-224. doi: 10.1159/000492941. Epub 2018 Oct 29.

6.

Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma.

Milone G, Martino M, Leotta S, Spadaro A, Zammit V, Cupri A, Avola G, Camuglia MG, Di Marco A, Scalzulli P, Morelli M, Olivieri A, Tripepi G.

Leuk Lymphoma. 2018 Jan;59(1):42-48. doi: 10.1080/10428194.2017.1324161. Epub 2017 Jun 2.

PMID:
28573902
7.

An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain.

Ronsisvalle S, Aricò G, Panarello F, Spadaro A, Pasquinucci L, Pappalardo MS, Parenti C, Ronsisvalle N.

Bioorg Med Chem. 2016 Nov 1;24(21):5280-5290. doi: 10.1016/j.bmc.2016.08.057. Epub 2016 Aug 30.

PMID:
27624520
8.

Caspase-3 activation in human melanoma A375 cell line by a novel selective sigma-2 agonist.

Ronsisvalle S, Arico G, Cova AM, Blanco P, Amata E, Pappalardo M, Pasquinucci L, Spadaro A, Ronsisvalle N.

Pharmazie. 2016 Mar;71(3):146-51.

PMID:
27183709
9.

Establishing a database of Canadian feline mitotypes for forensic use.

Arcieri M, Agostinelli G, Gray Z, Spadaro A, Lyons LA, Webb KM.

Forensic Sci Int Genet. 2016 May;22:169-174. doi: 10.1016/j.fsigen.2016.02.013. Epub 2016 Feb 27.

PMID:
26971852
10.

Left Main Ostial Compression in a Patient with Pulmonary Hypertension: Dynamic Findings by IVUS.

Seabra LF, Ribeiro HB, de Barros e Silva PG, Rodrigues MJ, Spadaro AG, Conejo F, Godinho RR, Faig SM, de Macedo TA, Baptista Lde P, de Resende MV, Furlan V, Ribeiro EE.

Am J Case Rep. 2015 Dec 23;16:899-903.

11.

Baccharis dracunculifolia-based mouthrinse alters the exopolysaccharide structure in cariogenic biofilms.

Aires CP, Sassaki GL, Santana-Filho AP, Spadaro AC, Cury JA.

Int J Biol Macromol. 2016 Mar;84:301-7. doi: 10.1016/j.ijbiomac.2015.12.015. Epub 2015 Dec 12.

PMID:
26691386
12.

Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study.

Olivieri I, Cortesi PA, de Portu S, Salvarani C, Cauli A, Lubrano E, Spadaro A, Cantini F, Ciampichini R, Cutro MS, Mathieu A, Matucci-Cerinic M, Punzi L, Scarpa R, Mantovani LG; PACE Working Group.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1):68-75. Epub 2015 Dec 3.

PMID:
26633622
13.

Does Ad Hoc Coronary Intervention Reduce Radiation Exposure? - Analysis of 568 Patients.

Truffa MA, Alves GM, Bernardi F, Esteves Filho A, Ribeiro E, Galon MZ, Spadaro A, Kajita LJ, Arrieta R, Lemos PA.

Arq Bras Cardiol. 2015 Nov;105(5):487-92. doi: 10.5935/abc.20150110. Epub 2015 Sep 8. English, Portuguese.

14.

Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families.

Tavarelli M, Russo M, Terranova R, Scollo C, Spadaro A, Sapuppo G, Malandrino P, Masucci R, Squatrito S, Pellegriti G.

Front Endocrinol (Lausanne). 2015 Aug 3;6:117. doi: 10.3389/fendo.2015.00117. eCollection 2015.

15.

Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey.

Cantini F, Lubrano E, Marchesoni A, Mathieu A, Olivieri I, Salvarani C, Scarpa R, Spadaro A.

Int J Rheum Dis. 2016 Aug;19(8):799-805. doi: 10.1111/1756-185X.12708. Epub 2015 Jul 14.

PMID:
26172207
16.

Evaluation of an Educational Program for Clinical Pharmacists to Conduct Standardized Assessments for Medication-Induced Movement-Related Disorders.

Spadaro A, Kellar J, Remington G, Sproule B, Al-Sukhni M, Chaiet A.

Can J Hosp Pharm. 2015 May-Jun;68(3):258-64. No abstract available.

17.

Comparison of conventional L-thyroxine withdrawal and moderate hypothyroidism in preparation for whole-body 131-I scan and thyroglobulin testing.

Marturano I, Russo M, Spadaro A, Latina A, Malandrino P, Regalbuto C.

J Endocrinol Invest. 2015 Sep;38(9):1017-22. doi: 10.1007/s40618-015-0318-3. Epub 2015 Jun 13.

PMID:
26070652
18.

Measuring psoriatic disease in clinical practice. An expert opinion position paper.

Lubrano E, Cantini F, Costanzo A, Girolomoni G, Prignano F, Olivieri I, Scarpa R, Spadaro A, Atzeni F, Narcisi A, Ricceri F, Sarzi-Puttini P.

Autoimmun Rev. 2015 Oct;14(10):864-74. doi: 10.1016/j.autrev.2015.05.010. Epub 2015 May 27. Review. Erratum in: Autoimmun Rev. 2016 Jan;15(1):112.

PMID:
26025585
19.

IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα production.

Yokota S, Yoshida O, Dou L, Spadaro AV, Isse K, Ross MA, Stolz DB, Kimura S, Du Q, Demetris AJ, Thomson AW, Geller DA.

J Immunol. 2015 Jun 15;194(12):6045-56. doi: 10.4049/jimmunol.1402505. Epub 2015 May 11.

20.

Development of lamellar gel phase emulsion containing marigold oil (Calendula officinalis) as a potential modern wound dressing.

Okuma CH, Andrade TA, Caetano GF, Finci LI, Maciel NR, Topan JF, Cefali LC, Polizello AC, Carlo T, Rogerio AP, Spadaro AC, Isaac VL, Frade MA, Rocha-Filho PA.

Eur J Pharm Sci. 2015 Apr 25;71:62-72. doi: 10.1016/j.ejps.2015.01.016. Epub 2015 Feb 12.

PMID:
25684193
21.

Local mitochondrial DNA haplotype databases needed for domestic dog populations that have experienced founder effect.

Spadaro A, Ream K, Braham C, Webb KM.

Forensic Sci Int. 2015 Mar;248:113-8. doi: 10.1016/j.forsciint.2014.12.025. Epub 2015 Jan 3.

PMID:
25612881
22.

Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review.

Lubrano E, Spadaro A, Amato G, Benucci M, Cavazzana I, Chimenti MS, Ciancio G, D Alessandro G, Angelis R, Lupoli S, Lurati AM, Naclerio C, Russo R, Semeraro A, Tomietto P, Zuccaro C, De Marco G.

Semin Arthritis Rheum. 2015 Apr;44(5):542-550. doi: 10.1016/j.semarthrit.2014.09.012. Epub 2014 Sep 28. Review.

PMID:
25450240
23.

Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs.

Perrotta FM, Addimanda O, Ramonda R, D'Angelo S, Lubrano E, Marchesoni A, Olivieri I, Punzi L, Salvarani C, Spadaro A.

Reumatismo. 2014 Nov 6;66(3):208-14. doi: 10.4081/reumatismo.2014.756.

24.

Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.

Mariani J Jr, Guedes C, Soares P, Zalc S, Campos CM, Lopes AC, Spadaro AG, Perin MA, Filho AE, Takimura CK, Ribeiro E, Kalil-Filho R, Edelman ER, Serruys PW, Lemos PA.

JACC Cardiovasc Interv. 2014 Nov;7(11):1287-93. doi: 10.1016/j.jcin.2014.05.024. Epub 2014 Oct 15.

25.

Common pathways toward informing policy and environmental strategies to promote health: a study of CDC's Prevention Research Centers.

Neri EM, Stringer KJ, Spadaro AJ, Ballman MR, Grunbaum JA.

Health Promot Pract. 2015 Mar;16(2):218-26. doi: 10.1177/1524839914553593. Epub 2014 Oct 9.

PMID:
25301898
26.

Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation.

Scrivo R, Conigliaro P, Riccieri V, Di Franco M, Alessandri C, Spadaro A, Perricone R, Valesini G.

Clin Exp Immunol. 2015 Feb;179(2):300-8. doi: 10.1111/cei.12449.

27.

Effects of intervertebral disc disorders of low back on the mandibular kinematic: kinesiographic study.

Spadaro A, Ciarrocchi I, Masci C, Cozzolino V, Monaco A.

BMC Res Notes. 2014 Aug 26;7:569. doi: 10.1186/1756-0500-7-569.

28.

Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis.

Scarno A, Perrotta FM, Cardini F, Carboni A, Annibali G, Lubrano E, Spadaro A.

World J Orthop. 2014 Jul 18;5(3):328-35. doi: 10.5312/wjo.v5.i3.328. eCollection 2014 Jul 18. Review.

29.

A novel biological target for the treatment of psoriatic arthritis.

Spadaro A, Montepaone M, Lubrano E.

Immunotherapy. 2014;6(5):515-8. doi: 10.2217/imt.14.39.

PMID:
24896622
30.

The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis.

Spadaro A, Lubrano E, Marchesoni A, Cauli A, Cantini F, Carotti M, D'Angelo S, Grassi W, Lapadula G, Macchioni P, Mathieu A, Punzi L, Ramonda R, Salaffi F, Salvarani C, Scarpa R, Olivieri I.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4):465-70. Epub 2014 May 21.

PMID:
24850468
31.

The effects of ULF-TENS stimulation on gnathology: the state of the art.

Chipaila N, Sgolastra F, Spadaro A, Pietropaoli D, Masci C, Cattaneo R, Monaco A.

Cranio. 2014 Apr;32(2):118-30. Review.

PMID:
24839723
32.

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis.

Montepaone M, Lubrano E, Carboni A, Spadaro A.

Open Access Rheumatol. 2014 Feb 20;6:7-13. eCollection 2014. Review.

33.

Effects of vitamin B12 on the corneal nerve regeneration in rats.

Romano MR, Biagioni F, Carrizzo A, Lorusso M, Spadaro A, Micelli Ferrari T, Vecchione C, Zurria M, Marrazzo G, Mascio G, Sacchetti B, Madonna M, Fornai F, Nicoletti F, Lograno MD.

Exp Eye Res. 2014 Mar;120:109-17. doi: 10.1016/j.exer.2014.01.017. Epub 2014 Jan 29.

PMID:
24486457
34.

Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies.

Lubrano E, Spadaro A.

BMC Musculoskelet Disord. 2014 Jan 20;15:25. doi: 10.1186/1471-2474-15-25.

35.

Unmet needs in outcome measures of Psoriatic Arthritis: focus on axial radiographic and nail involvement.

Lubrano E, Spadaro A.

Acta Biomed. 2013 Sep 1;84(2):87-93. Review.

PMID:
24165456
36.

Does orthodontic treatment provide a real functional improvement? a case control study.

Masci C, Ciarrocchi I, Spadaro A, Necozione S, Marci MC, Monaco A.

BMC Oral Health. 2013 Oct 24;13:57. doi: 10.1186/1472-6831-13-57.

37.

Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costs.

Milone G, Martino M, Spadaro A, Leotta S, Di Marco A, Scalzulli P, Cupri A, Di Martina V, Schinocca E, Spina E, Tripepi G.

Br J Haematol. 2014 Jan;164(1):113-23. doi: 10.1111/bjh.12606. Epub 2013 Oct 21.

PMID:
24138497
38.

First self-adjuvant multicomponent potential vaccine candidates by tethering of four or eight MUC1 antigenic immunodominant PDTRP units on a calixarene platform: synthesis and biological evaluation.

Geraci C, Consoli GM, Granata G, Galante E, Palmigiano A, Pappalardo M, Di Puma SD, Spadaro A.

Bioconjug Chem. 2013 Oct 16;24(10):1710-20. doi: 10.1021/bc400242y. Epub 2013 Sep 16.

PMID:
24041198
39.

Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients.

Costa L, Caso F, Atteno M, Giannitti C, Spadaro A, Ramonda R, Vezzù M, Del Puente A, Morisco F, Fiocco U, Galeazzi M, Punzi L, Scarpa R.

Clin Rheumatol. 2014 Feb;33(2):273-6. doi: 10.1007/s10067-013-2378-0. Epub 2013 Aug 24.

PMID:
23975363
40.

Rehabilitation and surgical management of ankylosing spondylitis.

Lubrano E, Astorri D, Taddeo M, Salzmann A, Cesarano E, Brunese L, Giganti M, Spadaro A.

Musculoskelet Surg. 2013 Aug;97 Suppl 2:S191-5. doi: 10.1007/s12306-013-0285-9. Epub 2013 Aug 15. Review.

PMID:
23949941
41.

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis.

Spadaro A, Scarno A, Carboni A, Perrotta FM, Catalano C, Lubrano E, Valesini G.

Reumatismo. 2013 Jul 24;65(3):134-7. doi: 10.4081/reumatismo.2013.134.

PMID:
23884030
42.

Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices.

Perrotta FM, Scarno A, Carboni A, Bernardo V, Montepaone M, Lubrano E, Spadaro A.

Reumatismo. 2013 Jul 23;65(3):105-12. doi: 10.4081/reumatismo.2013.105.

PMID:
23884025
43.

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study.

Spadaro A, Lubrano E, Marchesoni A, D'Angelo S, Ramonda R, Addimanda O, Perrotta FM, Olivieri I, Punzi L, Salvarani C.

Rheumatology (Oxford). 2013 Oct;52(10):1914-9. doi: 10.1093/rheumatology/ket249. Epub 2013 Jul 22.

PMID:
23878312
44.

Beyond anti-TNF-α agents in psoriatic arthritis.

Spadaro A, Lubrano E.

Expert Rev Clin Immunol. 2013 Jun;9(6):507-9. doi: 10.1586/eci.13.32.

PMID:
23730881
45.

Italian Society of Rheumatology recommendations for the management of gout.

Manara M, Bortoluzzi A, Favero M, Prevete I, Scirè CA, Bianchi G, Borghi C, Cimmino MA, D'Avola GM, Desideri G, Di Giacinto G, Govoni M, Grassi W, Lombardi A, Marangella M, Matucci Cerinic M, Medea G, Ramonda R, Spadaro A, Punzi L, Minisola G.

Reumatismo. 2013 Mar 28;65(1):4-21. doi: 10.4081/reumatismo.2013.4.

PMID:
23550256
46.

Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension.

Pellegriti G, Lumera G, Malandrino P, Latina A, Masucci R, Scollo C, Spadaro A, Sapuppo G, Regalbuto C, Pezzino V, Vigneri R.

J Clin Endocrinol Metab. 2013 Feb;98(2):458-65. doi: 10.1210/jc.2012-1952. Epub 2013 Jan 4.

PMID:
23293327
47.

Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor.

Milone G, Tripepi G, Martino M, Ancora F, Bartolozzi B, Spadaro A, Nozzoli C, La Fauci A, Amico I, Leotta S, Poidomani M, Irrera G, Iacopino P, Saccardi R, Guidi S, Bosi A.

Blood Transfus. 2013 Jan;11(1):94-101. doi: 10.2450/2012.0004-12. Epub 2012 Oct 10.

48.

Liquid crystalline phase nanodispersions enable skin delivery of siRNA.

Vicentini FT, Depieri LV, Polizello AC, Del Ciampo JO, Spadaro AC, Fantini MC, Vitória Lopes Badra Bentley M.

Eur J Pharm Biopharm. 2013 Jan;83(1):16-24. doi: 10.1016/j.ejpb.2012.08.011. Epub 2012 Sep 23.

PMID:
23010565
49.

Dental enamel, fluorosis and amoxicillin.

Ciarrocchi I, Masci C, Spadaro A, Caramia G, Monaco A.

Pediatr Med Chir. 2012 May-Jun;34(3):148-54. Review.

PMID:
22966729
50.

Evaluating the redistributive impact of public health expenditure using an insurance value approach.

Spadaro A, Mangiavacchi L, Moral-Arce I, Adiego-Estella M, Blanco-Moreno A.

Eur J Health Econ. 2013 Oct;14(5):775-87. doi: 10.1007/s10198-012-0423-6. Epub 2012 Sep 5.

PMID:
22948513

Supplemental Content

Loading ...
Support Center